Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size.

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

With over 100 publications in international journals, his groundbreaking work has earned him ... In 2014, he founded VectorBuilder, a revolutionary online platform for vector design and ordering that ...

Historically an active player in the M&A space, Radnor-based Avantor has not found itself so busy in that realm during the ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Emily McDermott, an entomology researcher, and Blythe Lawson, a Ph.D. student, tested fluralaner, a product commonly used to treat ticks and fleas on pets, to successfully target fly and mosquito ...

Jason Farned and his team at the San Gabriel Valley Mosquito and Vector Control District had spent years preparing for the ...

This study presents a valuable finding on the molecular mechanisms that govern GABAergic inhibitory synapse function. The authors propose that Endophilin A1 serves as a novel regulator of GABAergic ...

In a paper published in the journal Nature Physics, researchers used a superconducting quantum simulator to emulate charged ...

In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.